Piramal Pharma Ltd share price logo

Piramal Pharma Ltd

NSE: PPLPHARMA

BSE: 543635

Small Cap

Pharma Sector

₹203.01

+2.49

(+1.24%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Piramal Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-29%

Searches for Piramal Pharma on INDmoney have decreased by 29% over the last 30 days.

Investment activity on INDmoney

-14.66%

Investment activity in Piramal Pharma among INDmoney users has decreased by 14.66% over the last 30 days.

Among the most traded stocks

413th

Piramal Pharma was the 413th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

17 days

INDmoney investors hold Piramal Pharma shares for an average of 17 days.

Key Events for Piramal Pharma

Last Dividend Declared

₹0.14 per share, declared on 14/05/2025

View Dividend History

Piramal Pharma Stock Performance

as on October 7, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹199.99
    ₹205.10
    downward going graph

    1.49%

    Downside

    1.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹132.30
    ₹231.93
    downward going graph

    34.83%

    Downside

    14.25%

    Upside

    downward going graph

Piramal Pharma share price movements today

Previous Close
₹200.52
Open
₹200.06
Volume
22.98L
Upper Circuit
₹240.62
Lower Circuit
₹160.42
Day's Low - High
₹199.99 - ₹205.10
52 Week Low - High
₹132.30 - ₹231.93

Piramal Pharma Historical Returns

1 Month Return
-8.71 %
3 Month Return
+ 14.43 %
1 Year Return
+ 2.54 %
3 Year Return
+ 105.77 %
5 Year Return
+ 5.54 %

Piramal Pharma Fundamentals

as on October 7, 2026 at 4:01 pm IST

Market Cap

₹26,696.19 Cr

Return on Equity (ROE)

8.98

PE Ratio (TTM)

-84.61

Return on capital employed (ROCE)

10.77

Industry PE ratio

51.35

Beta (LTM)

1.17

P/B Ratio

2.22

Dividend Yield

0

PEG Ratio

27.21

Quarterly Earnings Growth YOY

-15.07

EPS (TTM)

-2.46

Book Value

61.5

Piramal Pharma Stock Valuation

as on October 7, 2026 at 4:01 pm IST

Piramal Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-1134.06x)

October 29, 2025

Today (-84.61x)

October 6, 2026

Industry (51.35x)

October 6, 2026

Highest (2011.42x)

June 25, 2024

LowHigh

Today’s Price to Earnings Ratio: -84.61x

Piramal Pharma Technical Analysis

Track how Piramal Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish
Bullish12
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.25
Bullish
CCI (20)
-45.71
Neutral
RSI (14)
65.62
Neutral
Momentum (10)
0.48
Bullish
ADI (14)
27.26
Bullish
Ultimate Oscillator (7,14,28)
67.51
Neutral

Moving Averages

Name

Value

Action

SMA (20)
203.12
Bullish
EMA (20)
203.19
Bullish
VWMA (20)
203.31
Bullish
SMA (50)
202.73
Bullish
EMA (50)
202.86
Bullish
SMA (200)
202.67
Bullish
EMA (200)
202.61
Bullish
KAMA (200)
202.9
Bullish
DEMA (200)
202.97
Bullish

Piramal Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Piramal Pharma Ltd image
Piramal Pharma Ltd
BUY26,696.191.11%0.71-3268,869
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD17,484.70-3.61%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,757.9611.03%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,389.51-6.24%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,591.2235.07%0.682811,703
See all

Market expectation of Piramal Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Piramal Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
1,958.57
2,552.36
1,951.14
2,241.75
2,204.22
2,754.07
1,933.71
2,043.72
2,139.87
2,751.77
2,269.92
Other Income
75.46
38.42
41.94
78.37
29.18
58.25
97.71
80.39
53.5
59.63
108.97
Total Income
2,034.03
2,590.78
1,993.08
2,320.12
2,233.4
2,812.32
2,031.42
2,124.11
2,193.37
2,811.4
2,378.89
Expenses
1,722.47
2,052.95
1,746.65
1,900.14
1,866.48
2,193.08
1,827.01
1,885.03
1,985.25
2,467.03
2,074.72
Operating Profit
236.1
499.41
204.49
341.61
337.74
560.99
106.7
158.69
154.62
284.74
195.2
Operating Profit Margin %
12.05%
19.57%
10.48%
15.24%
15.32%
20.37%
5.52%
7.76%
7.23%
10.35%
8.6%
Profit Before Interest, Tax and Depreciation
311.56
537.83
246.43
419.98
366.92
619.24
204.41
239.08
208.12
344.37
304.17
Interest
105.88
114.22
106.96
107.64
103.31
103.68
86.15
82.42
89.24
82.99
88.08
Depreciation
186.32
196.13
184.55
192.22
196.81
242.76
197.28
202.84
212.74
218.38
223.55
Profit Before Tax
19.36
227.48
-45.08
120.12
66.8
272.8
-79.02
-46.18
-93.86
43
-7.46
Tax Paid
9.25
126.21
43.56
97.53
63.12
119.3
2.68
53.04
42.33
51.83
61.93
Profit After Tax
10.11
101.27
-88.64
22.59
3.68
153.5
-81.7
-99.22
-136.19
-8.83
-69.39
Total Net profit including share of profit / Loss from associate company
10.11
101.27
-88.64
22.59
3.68
153.5
-81.7
-99.22
-136.19
-8.83
-69.39
EPS
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
-0.52
Actual EPS
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
-0.52
Adjusted EPS
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
-0.52
Diluted EPS
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
-0.52

Piramal Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
6,559.1
7,081.55
8,171.16
9,151.18
8,869.08
Other Income
334.83
279.44
234.88
207.74
270.5
Total Income
6,893.93
7,360.99
8,406.04
9,358.92
9,139.58
Expenses
5,624.52
6,460.27
7,037.69
7,706.35
8,143.6
Operating Profit
934.58
621.28
1,133.47
1,444.83
725.48
Operating Profit Margin %
14.25%
8.77%
13.87%
15.79%
8.18%
Profit Before Interest, Tax and Depreciation
1,269.41
900.72
1,368.35
1,652.57
995.98
Interest
198.25
344.18
448.49
421.59
340.8
Depreciation
586.18
676.69
740.57
816.34
831.24
Profit Before Tax
484.98
-120.15
179.29
414.64
-176.06
Tax Paid
109.02
66.31
161.47
323.51
149.88
Profit After Tax
375.96
-186.46
17.82
91.13
-325.94
Total Net profit including share of profit / Loss from associate company
375.96
-186.46
17.82
91.13
-325.94
EPS
3.19
-1.57
0.14
0.69
-2.46
Actual EPS
3.19
-1.57
0.14
0.69
-2.46
Adjusted EPS
3.12
-1.53
0.14
0.69
-2.46
Diluted EPS
3.19
-1.57
0.14
0.68
-2.46

Piramal Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
597.58
766.42
483.89
1,004.54
892.3
1,652.6
Cash Flow from Investing Activities
-4,464.39
-1,737.4
-1,333.63
-416.22
-488.34
-819.68
Cash Flow from Financing Activities
3,976.83
794.19
817.79
-422.36
-440.83
-38.98
Net Cash Flow
110.02
-176.79
-31.95
165.96
-36.87
793.94

Piramal Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
35.02%
35.02%
34.95%
34.95%
34.95%
34.95%
34.86%
34.86%
34.86%
34.86%
34.8%
DII
9.68%
12.12%
12.95%
13.81%
14.1%
14.78%
14.26%
14.89%
15.69%
15.61%
14.57%
FII
32.51%
30.59%
31.42%
31.73%
31.68%
31.49%
30.86%
30.27%
29.66%
30.18%
12.52%
Public
22.41%
21.89%
20.21%
19.07%
18.87%
18.44%
19.45%
19.47%
19.35%
19.01%
37.63%
Total Outstanding Shares
1,32,29,48,130
1,32,29,48,130
1,32,57,48,130
1,32,57,48,130
1,32,57,48,130
1,32,57,48,130
1,32,92,48,130
1,32,92,48,130
1,32,92,48,130
1,32,92,48,130
1,33,13,48,130
Total Shareholders
2,92,312
2,97,996
3,06,398
3,59,751
4,18,442
4,32,843
4,58,430
4,62,511
4,53,830
4,50,661
4,61,096

Piramal Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Piramal Pharma.

  • Piramal Pharma Ltd Earnings Results

    Piramal Pharma Ltd’s net profit jumped 15.07% since last year same period to ₹-69.39Cr in the Q1 2026-2027. On a quarterly growth basis, Piramal Pharma Ltd has generated -685.84% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Piramal Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Piramal Pharma Ltd has declared dividend of ₹0.14 per share on 14 May 2025 - translating a dividend yield of 0.07%.

    Read More about Dividends

Indices Featuring Piramal Pharma Stock

Check stock indices that include Piramal Pharma.

S&P BSE 250 SmallCap

₹7,028.59

+1.62 (▲0.02%)

S&P BSE SmallCap Select

₹9,141.03

+15.71 (▲0.17%)

Nifty MidSmallcap 400

₹20,445.70

-78.90 (▲0.38%)

Nifty Smallcap 250

₹17,917.75

+15.45 (▲0.09%)

Nifty Smallcap 50

₹9,728.50

+27.60 (▲0.28%)

BSE Healthcare

₹49,741.46

-145.08 (▲0.29%)

BSE 500

₹34,509.01

-217.56 (▲0.63%)

Nifty Small 100

₹19,506.95

+58.25 (▲0.30%)

NIFTY PHARMA

₹26,436.55

-113.05 (▲0.43%)

S&P BSE 400 MidSmallCap

₹12,222.22

-50.74 (▲0.41%)

Nifty 500

₹22,059.90

-142.95 (▲0.64%)

Insights on Piramal Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, PPLPHARMA stock has moved up by 42.2%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 12.22% to 12.52% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 19.01% to 37.63% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Divis Laboratories Ltd has given 157.7% return, outperforming this stock by 52.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 56.4% return, outperforming this stock by 53.9%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 14.12% to 13.18% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 34.86% to 34.80% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.81K Cr → 2.37K Cr (in ₹), with an average decrease of 15.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -8.83 Cr → -69.39 Cr (in ₹), with an average decrease of 685.8% per quarter

About Piramal Pharma Ltd

Piramal Pharma Limited is an integrated company offering products and services through manufacturing capabilities and global distribution. The business is divided into three main parts - CDMO CHG and ICH - and offers services such as drug discovery, clinical development and active pharmaceutical ingredient commercialisation. Through its 15 global manufacturing facilities and a global distribution network in over 100 countries, the company offers a range of self-care products and unique capabilities in areas such as antibody drug conjugates and biologics. The company has achieved multiple milestones in 2020 and 2021, such as acquiring the pharmaceutical business from Piramal Enterprises Limited, receiving growth equity investment from The Carlyle Group, and expanding its capabilities in Grangemouth and Riverview. In 2022, Piramal Pharma Limited acquired a minority stake in Yapan Bio Private Limited. Overall, the company is experienced in providing global delivery capabilities for its customers and has a diversified manufacturing footprint allowing for market proximity and cost efficient production.

Revenue: ₹2,269.92Cr as on June 2026 (Q1 FY27)
Net Profit: ₹-69.39Cr as on June 2026 (Q1 FY27)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
OrganisationPiramal Pharma Ltd
IndustryPharmaceuticals
CEONandini Piramal
E-voting on sharesClick here to vote

FAQs

What is Piramal Pharma share price today?

Piramal Pharma share price today stands at ₹203.01 as on at the close of the market. Piramal Pharma share today touched a day high of ₹205.1 and a low of ₹199.99.

What is the 52 week high and 52 week low range for Piramal Pharma share?

Piramal Pharma touched a 52 week high of ₹231.93 and a 52 week low of ₹132.3. Piramal Pharma share price today i.e. is closed at ₹203.01, which is -12.47% down from its 52 week high and 53.45% up from its 52 week low.

What is Piramal Pharma's market capitalisation today?

Piramal Pharma market capitalisation is ₹26,696.19 Cr as on .

How to buy Piramal Pharma shares?

To buy Piramal Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PPLPHARMA or Piramal Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Piramal Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Piramal Pharma trading volume today?

Piramal Pharma trading volume is 22.98L as on . This means that 22.98L shares of Piramal Pharma were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Piramal Pharma shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Piramal Pharma have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 17 days. This reflects platform activity only and is not investment advice.